-
1
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
Опубликовано 2025Предметы: -
2
-
3
-
4
-
5
Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
Опубликовано 2025Предметы: -
6
-
7
-
8
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
9
Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
Опубликовано 2025Предметы: -
10
-
11
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
12
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
13
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
14
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
15
-
16
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
17
-
18
-
19
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Опубликовано 2025Предметы: -
20